![]() | ![]() |
Formats:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. Preventing Childhood Malaria in Africa by Protecting Adults from Mosquitoes with Insecticide-Treated Nets 1 Ifakara Health Research and Development Centre, Ifakara, Morogoro, United Republic of Tanzania 2 Department of Biological and Biomedical Sciences, University of Durham, Durham, United Kingdom 3 Department of Public Health and Epidemiology, Swiss Tropical Institute, Basel, Switzerland 4 Division of Infection and Immunity, Glasgow University, Glasgow, United Kingdom 5 Division of Environmental and Evolutionary Biology, Glasgow University, Glasgow, United Kingdom 6 United States Public Health Service Commissioned Corps and Malaria Branch, Division of Parasitic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America Jonathan Dushoff, Academic Editor Princeton University, United States of America * To whom correspondence should be addressed. E-mail: gkilleen/at/ihrdc.or.tz Received December 22, 2006; Accepted May 16, 2007. This article has been cited by other articles in PMC.Abstract Background Malaria prevention in Africa merits particular attention as the world strives toward a better life for the poorest. Insecticide-treated nets (ITNs) represent a practical means to prevent malaria in Africa, so scaling up coverage to at least 80% of young children and pregnant women by 2010 is integral to the Millennium Development Goals (MDG). Targeting individual protection to vulnerable groups is an accepted priority, but community-level impacts of broader population coverage are largely ignored even though they may be just as important. We therefore estimated coverage thresholds for entire populations at which individual- and community-level protection are equivalent, representing rational targets for ITN coverage beyond vulnerable groups. Methods and Findings Using field-parameterized malaria transmission models, we show that high (80% use) but exclusively targeted coverage of young children and pregnant women (representing <20% of the population) will deliver limited protection and equity for these vulnerable groups. In contrast, relatively modest coverage (35%–65% use, with this threshold depending on ecological scenario and net quality) of all adults and children, rather than just vulnerable groups, can achieve equitable community-wide benefits equivalent to or greater than personal protection. Conclusions Coverage of entire populations will be required to accomplish large reductions of the malaria burden in Africa. While coverage of vulnerable groups should still be prioritized, the equitable and communal benefits of wide-scale ITN use by older children and adults should be explicitly promoted and evaluated by national malaria control programmes. ITN use by the majority of entire populations could protect all children in such communities, even those not actually covered by achieving existing personal protection targets of the MDG, Roll Back Malaria Partnership, or the US President's Malaria Initiative. Editors' Summary Background. Malaria—a parasitic disease common in tropical and subtropical countries—causes about a million deaths every year, mainly among young children and pregnant women living in sub-Saharan Africa. The parasite responsible for most of these deaths is Plasmodium falciparum. Like all malaria parasites, it has a complex life cycle, part of which takes place inside mosquitoes. When a malaria-carrying mosquito bites a person (usually at night), parasites enter the human blood stream and travel to the liver where they reproduce before invading red blood cells. Here, they multiply again before bursting out and infecting more red blood cells as well as causing a high fever and sometimes damaging the nervous system, liver, and kidneys. When a mosquito bites someone who is infected, it often picks up parasites in its blood meal (mosquitoes need mammalian blood for successful reproduction), thus completing the malarial transmission cycle. Why Was This Study Done? One way to break this cycle and reduce malarial transmission is to decrease the number of contacts between people and mosquitoes by encouraging people to sleep under insecticide-treated nets (ITNs). Field studies have shown that ITN use reduces deaths from malaria, so the Roll Back Malaria Partnership, the United Nations Millennium Development Goals, and the US President's Malaria Initiative have set a target of at least 80% use of ITNs by young children and pregnant women (the people most vulnerable to malaria) by 2010. But would broader population coverage with ITNs interrupt the malarial transmission cycle more effectively? Might the wider use of ITNs (which both directly kill mosquitoes and repel them so that mosquitoes have to travel farther to get the blood they need to reproduce) be a more effective way to reduce local mosquito numbers and, consequently, human–mosquito contacts and malarial transmission? In this study, the researchers used mathematical modeling to ask how much community-wide coverage with ITNs is needed to protect vulnerable individuals against malaria without them personally using an ITN. What Did the Researchers Do and Find? The researchers developed a model for the transmission of the malaria parasite using data collected in Tanzanian villages where malaria is common, and used it to investigate how different patterns of ITN use might affect the individual protection of ITN users and the communal protection of nonusers. High (80%) coverage targeted at young children and pregnant women (less than 20% of the population) provided limited but valuable protection to these vulnerable individuals. However, the model predicted that a similar degree of community-wide protection would result if 35% of the whole population slept under ITNs provided there was no nonhuman blood supply for the mosquitoes. In other words, the vulnerable individuals in the population received the same degree of protection from this intervention as they would have got from personally using an ITN. If an alternative blood supply for the mosquitoes (for example, cattle) was included in the model, just over half of the population needed to sleep under ITNs to provide the same degree of community-wide protection as targeted ITN use. What Do These Findings Mean? Although the use of ITNs by vulnerable groups should remain a priority, these findings suggest that the wide-scale ITN use by the entire population should also be promoted. The use of ITNs by about half the population, predict the researchers, could protect all the young children in that population, even those who did not sleep under a net. As with all mathematical models, the accuracy of this prediction depends on the assumptions and data incorporated into the model. So before recommending community-wide use of ITNs, the actual level of communal protection provided by increased ITN coverage must be measured by rigorously evaluating ongoing national programmes. If such surveillance data confirm this model's predictions, wide coverage with ITNs might do more for public health in Africa than previously thought, suggest the researchers, provided the financial and logistical challenges associated with achieving high ITN coverage in this poor region of the world can be solved. Additional Information. Please access these Web sites via the online version of this summary at http://dx.doi.org/10.1371/journal.pmed.0040229.
Introduction The massive malaria burden in Africa merits particular attention as the world struggles to realize a better life for the poorest [1,2]. The Anopheles mosquitoes that act as vectors for human Plasmodium parasites must access sugar, blood, and aquatic oviposition sites to complete their life cycle and maintain parasite transmission. The availability of such ecological resources to mosquitoes has long been recognized as a crucial determinant of malaria transmission [3], but quantitative understanding of this process, as well as viable means to prevent it, remain poorly developed compared with other disease [4] and pest systems [5]. Recent theoretical work highlights the enormous influence of blood source and aquatic habitat availability in determining malaria transmission intensity, disease burden, and their responsiveness to various forms of control [6–12]. Here we apply field-parameterized kinetic models of mosquito host availability [11,13] to identify important shortcomings of current global targets for delivering insecticide treated nets (ITNs) [2,14,15], the most important vector control tool in Africa today. Not only does the model outline the limitations of existing strategies that emphasize targeting of vulnerable groups such as young children and pregnant women [16–18], it also indicates how complementary strategies to promote coverage of whole populations, including nonvulnerable adults and older children [19], will achieve greater and more equitable reduction of disease burden than otherwise would be possible. Insecticide-treated nets (ITNs) represent a practical and effective means to prevent malaria in Africa [20], so scaling up coverage to at least 80% use by young children and pregnant women by 2010 is a consensus target of the Millennium Development Goals (MDGs), the Roll Back Malaria Partnership, and the US President's Malaria Initiative [2,14,15]. Targeting individual protection to these vulnerable groups [16–18] is a well-founded and explicitly accepted priority of all three initiatives, because these groups bear the highest risk of morbidity and mortality from malaria. However, this strategy largely ignores the potentially greater community-wide benefits of broader population coverage [19], and no explicit resources, targets, or strategies have been proposed to achieve these benefits. ITNs can protect not only the individuals and households that use them, but also members of the surrounding community [19,21–26]. This is because they kill adult mosquitoes directly or force them to undertake longer, more hazardous foraging expeditions in search of vertebrate blood and aquatic habits [11]. Plasmodium falciparum, the malaria parasite responsible for the bulk of deaths in Africa, requires at least 8 d to develop from imbibed gametocytes into mature sporozoites within the salivary glands of the vector mosquito. This means that most malaria transmission is carried out by mosquitoes that are at least 10 d old and have taken several previous blood meals at intervals of 2–5 d [27,28]. By even modestly increasing mosquito mortality while they attempt to feed on humans, ITNs can greatly reduce the number of mosquitoes that survive repeated hazardous encounters with protected humans [11]. Also, the excito-repellent properties of ITNs can reduce the frequency with which mosquitoes successfully acquire blood, often diverting them to feed on other mammals that do not host the malaria parasite, resulting in greatly reduced prevalence of sporozoite infection [11]. This theoretical rationale is strongly supported by detailed observations from experimental hut studies [29–34] and from larger village-scale trials: ITNs have been clearly shown to reduce malaria risk among unprotected individuals by suppressing the density [35–37], survival [35–37], human blood indices [38,39], and feeding frequency [39] of malaria vector populations. Large reductions of transmission are required to appreciably reduce malaria burden in most of Africa [17,40], particularly in the longer term as exposure and immunity re-equilibrate [41]. ITNs can address this challenging need through direct personal protection and area-wide suppression of the malaria transmission intensity that benefits even nonusers. It has been suggested that such communal benefits can make large impacts on disease burden only if appreciable levels of coverage are achieved in the human population as a whole [11,12,19], but precise coverage targets for achieving this remain to be determined. So how much coverage is enough to protect individuals who do not use an ITN? Methods Overview Here we used recently developed kinetic models of mosquito behaviour and mortality [11,13] to answer this question by considering the impact of ITNs on human host availability and feeding hazards to mosquitoes, as well as the consequences of such changes for malaria transmission intensity. Protection was estimated in terms of protection against exposure to infectious mosquito bites, expressed as the relative change in the entomological inoculation rate (EIR). EIR is a proven epidemiological indicator of malaria transmission intensity and a key determinant of disease burden [17,40]. Two common but ecologically distinct African malaria transmission systems are considered. First, we modelled an Anopheles gambiae Giles or An. arabienis Patton (sibling species from the same species complex known as An. gambiae sensu lato) population with access to human blood only. Second, we considered An. arabiensis populations in the presence of abundant cattle, which can act as alternative blood sources. An. gambiae greatly prefers humans, but An. arabiensis will readily feed upon cattle [42,43], so populations of these species respond quite differently to increasing ITN coverage, with malaria transmission by the latter typically being lower to begin with but less sensitive to control with ITNs [11]. In both transmission systems we considered ITNs with properties typical of those evaluated in rigorous clinical trials [20] or those of emerging technologies with improved operational durability [44–47]. Note that coverage is expressed as the proportion of the total human population using an ITN each night, rather than in terms of ownership, because this value is the most direct indicator of both personal and communal protection. Figure 1
The specific modelling approach described here is almost identical to our recent exploration of the optimal properties of ITNs as a function of local ecology [11], apart from subtle improvements in terms calculating mosquito diversion, mortality, and feeding probabilities per host encounter. It is also similar to and consistent with the approaches of others [6,12] but accounts for the fact that ITNs can act only during times of the night when they are actually in use, so that their overall protection is also influenced by subtle variations in the behavioural interactions between humans and mosquitoes [13]. This model has already been evaluated through improved iterations in terms of sensitivity to variations in the assumed parameter values for the insecticidal and excito-repellent properties of ITNs [11], the survival rate of mosquitoes while foraging for resources [11], the innate resource preferences of vector populations [11,50,52], and the availability of those resources, including oviposition sites [50] and alternative blood meal hosts [11,50]. While the analysis outlined here could be implemented with either of the recently developed (and perhaps more elegant) alternative models [6,12], this particular form captures all of the same processes without necessitating the mathematical subtleties of integration, differentiation, equilibrium analysis, or limits. While these are inherently valuable tools for mathematical modelling, they often constitute “black boxes” to nonmathematicians, including several authors of this article. We therefore chose a model that does not require mathematical complexities that might limit accessibility to some of the field biologists and epidemiologists for whom this analysis is most relevant. The model is presented as a downloadable spreadsheet (see Protocol S1) and has proven valuable for teaching the ecological basis of malaria epidemiology and control to students in both the developed and developing world. Modelling Mosquito Behaviour and Mortality at the Individual Level Here we describe a submodel of behavioural and mortality processes that occur at the level of individual mosquitoes seeking, encountering, attacking, and feeding upon individual blood hosts. Another important simplification to consider is that, like most deterministic malaria transmission models, our approach assumed a “malaria in a bottle” scenario in which populations of identical parasites, vectors, and hosts are mixed homogenously within an enclosed system [53]. One important corollary of this assumption is that well-established variations of vulnerability to malaria infection within human populations [16,17] or associated variations in attractiveness and availability to mosquitoes [9,54–56] are not explicitly modelled. As defined previously [52], the availability (a) of any host (j) of any species (s) is the product of the rate at which individual vectors encounter it ( s,j) and the probability that, once encountered, they will feed upon it ( s,j):
Note that this kinetic definition of availability as a rate per unit time is consistent with applications of the same term to acquisition of oviposition sites [10], the term attraction rate for blood sources [6,57], and the terms feeding rate and oviposition rate for both resources [8,12]. We considered successful feeding as just one of three possible outcomes of a host encounter by a female vector, the other two being death while attempting to feed and diversion to seek another host (Figure 1
We then considered the second stage of the blood acquisition process, namely feeding. Knowing the probabilities that the vector will either feed successfully ( s) or die in the attempt (μs) per attack (rather than per encounter) allowed us to calculate the probability of a successful feed per encounter:
Specifically, the cases of cattle (c) and unprotected humans (h,u) were dealt with in a straightforward manner as follows, where Δu and μu represent a common parameter value for both types of host (Table 1):
Personal protection measures such as bed nets, repellents, or domestic insecticide use were envisaged as three possible outcomes, the probabilities of which sum to 1: For a vector that would normally choose to feed upon an encountered unprotected human with a probability of h,u, the presence of a net or other intervention is expected to influence this probability for protected humans ( h,p) as a function of the excess probability of diverting (Δp) and killing (μp) that vector (Figure 1 + p) or mortality (μu + p) were calculated as follows:
These parameters allowed us to calculate the feeding probability for a human who always uses and is protected by a net ( h,p):
These equations are parameterized using data from experimental hut trials in which the human participants slept within the net throughout the period of data collection (Table 1). However, very few human beings spend their entire day asleep or using a net [13] so the true probability of feeding upon a typical net user (
) is calculated by weighting h,u and h,p according to the proportion of normal exposure during which the host is actually covered (πi):
Equations 5-7 differ slightly from those previously proposed [11], which treated diversion and killing as independent events, conditional on the host having and using a net. At low values of πi these changes relative to [11] make little difference, but the model described here is more realistic at high values of πi. Extrapolating Impacts of Insecticide-Treated Nets to the Community Level Given the above submodel for the interactions of mosquitoes with individual mammalian hosts, it was possible to extrapolate the likely large-area effects of these small-scale influences on entire vector populations and the human communities they feed upon. For any given number of cattle (Nc), unprotected humans (Nh,u), and protected humans (Nh,p), the mean seeking interval for vertebrate hosts (ηv) can be calculated as the reciprocal of total host availability (A) [52], using estimates of these feeding probabilities and their corresponding encounter rates, adapting Equation 1 from our original formulation [50]:
Foraging for resources is an intrinsically dangerous undertaking for mosquitoes, and it is commonly assumed that survival during these phases is lower than while resting in houses [6,60]. We adapted Equation 3 from our previous formulation [50] to estimate the survival rate per feeding cycle (Pf) as the product of the probability of surviving the eventual attack on a host that may be protected (Pγ) and the probabilities of surviving the gestation (g), oviposition site-seeking (ηo), and vertebrate host-seeking (ηv) intervals, with distinct daily survival probabilities for the resting (P), foraging for either oviposition sites or vertebrate hosts (Pov), and attacking (Pγ) phases:
The mean probability of mosquitoes surviving their eventual chosen host attack (Pγ) was calculated assuming that the proportion of all attacks that end in death is the sum of the mortality probabilities for attacking protected and unprotected hosts, weighted according to the proportion of all encounters that will occur on such hosts. Assuming that protection does not affect encounter rates, and that these rates are proportional to availability when unprotected, we applied this weighting approach to estimate total attack-related mortality rate and consequent survival as follows:
Similarly, the human blood index is calculated as the proportion of total host availability accounted for by humans [52], similarly to Equation 9:
The EIR for protected and unprotected individuals was then calculated from the total number of infectious bites upon humans that occur in the population as a whole (β E) [27,49], the share of the total human availability represented by that group, and the population size of that group:
Otherwise, we modelled malaria transmission exactly as previously described [50]. Note that this model has been adapted [11,50] from its original formulation [27] to account for superinfection of mosquitoes [28] and daily time increments to smooth the effects of changing host availability patterns on feeding cycle length [50]. For ease of comparison and interpretation, the impact of ITNs is presented in terms of the relative transmission intensity EIRC/EIR0 at a given coverage level (C; note distinction from c, which denotes cattle hosts) as a result of personal and communal protection amongst users and nonusers:
Baseline Mosquito Behaviour, Host Availability, and Survival Parameters The parameter definitions and values used to implement this analysis are summarized in Table 1. Namwawala, in the Kilombero Valley, southern Tanzania is the primary centre for parameterising our model because of the exceptionally detailed quantitative characterisation of malaria transmission and vector biodemography in this village and the surrounding area. This is a holoendemic village with intense seasonal transmission, stable high parasite prevalence in humans, and a heavy burden of clinical malaria [61–68]. At this site the bulk of transmission is mediated by An. gambiae sensu lato (of which the main species involved in transmission is An. arabiensis) and transmission intensity has been modelled with available field data [27,49]. As previously described [27,49], we based our estimate of human population size [62] approximately upon those reported for this particular village during the early 1990s. Nevertheless, we used a human population size of 1,000 and, where relevant, a bovine population of the same size so that the EIR experienced by users and nonusers could be easily calculated at net coverage levels approaching 0% and 100%. By setting coverage to 0.001 or 0.999, this model simulates a single user or nonuser in the population, respectively. Infectiousness of humans (κ) is set to 0.030, reflecting a more precise recent estimate [69] than was available previously [61,63]. In a typical holoendemic scenario, the infectiousness of the human population is thought to be largely insensitive to reductions in transmission intensity [69]. In the interests of making conservative and generalizable predictions, we assumed that increasing coverage with ITNs will not affect κ [69], even though reduction of κ is likely at EIR values below 10 infectious bites per person per year [56]. We set mean daily survival of the resting phase (P) at 0.90, reflecting a median value of daily survival at four well-characterised holoendemic sites [27] and estimated daily indoor survival for An. gambiae s.l. in Tanzania [70]. As previously described, the daily survival rate of mosquitoes while foraging for blood or oviposition sites (Pov) was set at 0.80, representing a median value of plausible field values [11]. The results of experimental hut studies [34] were combined with host-choice evaluations [71] and appropriate analytical models [50,52] to define the attack and mortality probabilities of An. arabiensis encountering cattle or humans: we set the probability that An. arabiensis will attack unprotected cattle or humans (γu), conditional upon encountering them, to be 0.90 and the chance that they will die in the attempt (μu) at 0.10. Using these parameters and Equation 3, we calculated that, for An. arabiensis, the overall feeding probability upon either cattle ( c) or unprotected humans ( h,u) would be 0.81, a value similar to previous estimates of approximately 0.80–0.85 for the feeding success of An. gambiae sensu lato on sleeping humans in Tanzania [34,62]. We also applied these same probabilities of attacking (γu), feeding ( h,u), and dying (μu) to An. gambiae sensu stricto encountering unprotected humans. The availabilities of unprotected humans and cattle were calculated for An. arabiensis using field measurements of the duration of the feeding cycle and were extended to An. gambiae s.s., accounting for the lower estimated relative availability of cattle (λc) to this mosquito species as previously described [52]. Note that λc is assumed to modify ac by affecting the encounter rate only, indicating that these mosquitoes can differentiate between preferred and nonpreferred hosts at long ranges [72–74]. In the case of An. arabiensis this assumption is consistent with the longer spatial range of attraction of cows relative to humans for zoophilic members of the An. gambiae complex [72–74].Parameters Reflecting the Effects of Insecticide-Treated Bed Nets The parameter definitions and values describing the impacts of ITNs on vector behaviour and mortality at the level of individual interactions are listed in Table 1. The impacts of ITNs very much depend on their excito-repellent and insecticidal properties, which are most representatively evaluated using well-established experimental hut methodologies [59,75,76] that have been extensively applied to this particular intervention [29–34]. Furthermore, the interaction of these two properties, to yield varying levels of personal and communal protection, is complex and has crucial implications for ITN programmes across Africa [11]. Sensitivity analysis of models similar to those used in this paper [11] have previously been used to explore the influence that these properties might have upon the magnitude and equity of protection afforded by ITNs (Figure 2
Figure 2 We therefore concluded that the simulations described in the main text should consider ITNs with both insecticidal and excito-repellent properties, consistent with those of products currently on the market that have been evaluated in a variety of settings and experimental designs. To simulate the likely properties of established ITNs under programmatic conditions, we conservatively assumed they will both divert and kill 40% more mosquitoes than an unprotected human (μp = 0.4 and Δp = 0.4). A net with such proper-ties would protect against 64% of indoor exposure (1 − [(1 − 0.4) × (1 − 0.4)] = 0.64), as measured in a typical experimental hut trial [46,76]. To explore the best possible future scenario for the development of highly durable ITNs [44–47] or regular retreatment services [82], we also simulated increasing co-verage with nets that divert and kill 80% more mosquitoes than with an unprotected human (μp = 0.8 and Δp = 0.8), providing 96% protection (1 − [(1 − 0.8) × (1 − 0.8)] = 0.96). The proportion of normal biting exposure that occurs while nets are actually in use (πi) has been estimated as 90% for A. gambiae in southern Tanzania [13], so we set πi to a value of 0.90. Results Figure 3
The insecticidal and excito-repellent properties of ITNs that define levels of personal protection also determine the extent of community-wide alleviation of exposure amongst users and nonusers alike [11], so improved ITN properties consistently result in improved overall impact. In our model, slightly higher usage rates were required to achieve equivalence of individual and communal effects, with thresholds of 40% and 64% coverage for vector populations with and without alternative hosts, respectively (Figure 3 Discussion In addition to the direct impacts on vector populations explicitly modelled above, coverage of adults and older children is likely to have further benefits arising from subtleties of mosquito resource utilization that are often under-appreciated. Over 80% of human-to-mosquito transmission originates from adults and children over five years of age, because these groups constitute the bulk of the population and are more attractive to mosquitoes [56]. Where the entomological inoculation rate is fewer than ten infectious bites per person per year, the distributions of infectiousness [56,69], morbidity, and mortality will all shift into these older age groups, necessitating protection of all members of the population. Under such conditions, ITNs could suppress transmission not only through direct impacts on mosquito mortality, host choice, and feeding frequency [11], but also by limiting the prevalence, density, and infectiousness of malaria parasites in the human population [56]. An under-emphasized feature of communal protection is the enhancement of ITN programme equity, regardless of ecological scenario or ITN effectiveness: If the majority of people living in malaria-endemic Africa regularly used existing ITN technologies, nonusers would receive communal protection at least equivalent to using the only ITN in an otherwise unprotected population (Figure 3 The choice of ITN delivery strategy has proven contentious in recent years [89,90], but proponents of both market-based and public-sector approaches equally emphasize targeting strategies [9,16,84] to enhance equity and minimize leakage of subsidized ITNs beyond intended target groups [91–94]. While optimal targeting of finite subsidies is highly desirable, there are fundamental limitations to the impact that can be achieved: Even if resources were perfectly targeted, 80% coverage of pregnant women and children under five years of age could be accomplished with less than 20% coverage of the whole population, and even less of the total human host availability [11,56], as well as the infectious parasite reservoir [56,69]. Even if the ITN coverage targets of the MDGs were attained with flawless targeting efficiency, the substantial and equitable benefits of communal protection would not be achieved. Specifically, the target of 70% less exposure to transmission [13] would not be attained by the remaining minority of vulnerable individuals who are not covered and do not use an ITN, regardless of ecological scenario or ITN properties (Figure 3 Specifically, we conclude that protecting the vulnerable can achieve maximum public health impact only if complemented by strategies that also achieve broad coverage of the population as a whole. In reality, the targets for coverage of vulnerable groups will not be reached without some leakage and inequity. Our analysis suggests that such concerns may be less of a problem than the targets themselves and may be minimized by extending coverage priorities to include all age groups. Fortunately, consensus is finally emerging that a range of approaches to ITN deployment merit investigation, development, and comparative evaluation at scales for which no precedent yet exists [95]. Note that this analysis supports the implementation of any of the diverse and rapidly emerging delivery strategies as long as high coverage with long-lasting ITNs is sustained across entire malaria-endemic populations on national scales. Perhaps the most important remaining question is: How can such population-wide coverage levels be affordably and cost-effectively sustained? Growing financial support for malaria control globally [14,15,95] may enable fully subsidized provision to entire populations [82] of the world's most impoverished, malaria-afflicted nations. Existing evidence, based largely on individual protection alone, indicates that ITNs are as cost-effective as childhood immunization [96], and future analyses should explicitly consider the additional benefits of communal protection. Implementing this goal may be relatively straightforward for programmes that are primarily subsidized and implemented through the public sector, such as recent successful initiatives associated with vaccination campaigns [91]. By comparison, social marketing approaches, including hybrid systems that deliver public subsidies through the private sector, may require more detailed consideration, particularly where cost sharing with the target population is substantial and biased toward the nonpregnant adults and older children who are key to communal protection. Although social marketing approaches to ITN distribution face substantial challenges [93,97,98], notable success in terms of coverage and impact have been reported in a variety of settings [94,99,100], including the KINET programme in Kilombero Valley, southern Tanzania where ITNs have been promoted and subsidized since 1996 [77,78]. Much of the essential experience generated by KINET was later integrated into the ITN promotion strategy of the National Malaria Control Programme of Tanzania, which supports private sector distribution through a voucher system that subsidizes purchase by vulnerable priority groups [101]. In the meantime, the preceding KINET pilot in Kilombero has achieved 75 % net use amongst randomly sampled residents of all ages (Killeen et al., unpublished data). It is particularly noteworthy that substantial levels of communal protection were achieved [102] (unpublished data) even though most of these nets were untreated or poorly treated at the time of evaluation [79] (unpublished data). Reassuringly, the model applied here approximately reproduces these patterns of communal protection using plausible parameter estimates for the net properties, vector behaviours, and host demographics of the area (unpublished data). We therefore recommend that the cost-effectiveness of such hybrid approaches be explicitly evaluated in terms of the complementary respective contributions of public-sector subsidies and cost-sharing by target populations to personal and communal protection. While appropriate engagement and sensitization of malaria-afflicted populations is essential to the success of any ITN promotion programme, this is likely to be especially true where cost-sharing by the target population will be needed to complement limited public subsidies. Such cost-sharing schemes may be the only affordable means to support full population coverage where available subsidies are inadequate. In such resource-limited circumstances, high levels of awareness, acceptance, and willingness to pay will be essential to enable concerted use of ITNs by adults and shared protection of all children within their communities. Overly confident extrapolation from mathematical models to set operational targets for malaria control has proved to be a grave mistake in the past [103]. A number of complications not captured by this model could emerge as ITN coverage increases, not least of which might be increased selection for insecticide resistance [104,105]. While we urge caution in interpreting the numerical results of our analysis, the phenomenon outlined is well established and has clear implications for malaria control in Africa and beyond [19]. In fact, the analysis presented here provides a generalizable rationale that strongly supports the conclusions of the most recent and meticulous evaluations of the community-level benefits of ITNs: “High coverage with ITNs will do more for public health in Africa than previously imagined” [19]. We therefore suggest that further field data, analyzed with appropriate theoretical models and cost-effectiveness frameworks, are required to verify and quantify the levels of communal protection afforded by increasing ITN use across Africa. International targets [2,14,15] should be amended to include thresholds for coverage of entire populations and monitored accordingly. By making life increasingly difficult for mosquitoes through programmes that promote ITN use by the majority of their human victims, it may be possible to protect the 15%–20% of children and pregnant women in African communities who would not otherwise be covered even if existing personal protection targets of the MDGs [2], the Roll Back Malaria Partnership [14], or the U.S. President's Malaria Initiative [15] were to be achieved. Protocol S1: Model Spreadsheet A Microsoft Excel spreadsheet version of all model simulations presented here is available to download. (1.1 MB XLS) Click here for additional data file.(1.1M, xls) Acknowledgments We thank Dr. R. Nathan and the Ifakara Health Research and Development Centre demographic surveillance team for providing ITN coverage data, and the people of the Kilombero Valley in southern Tanzania for cheerfully participating in the series of surveys leading to this work. We thank Dr. R. Nathan, Dr J. R. M. Armstrong-Schellenberg, Dr. L. Slutzker, and Prof. S. W. Lindsay for their critical comments on the manuscript. The findings and conclusions presented in this paper are those of the authors and do not necessarily represent those of the United States Public Health Service nor the Centers for Disease Control and Prevention. This paper is published with kind permission of Dr A. Kitua, Director of the National Institute for Medical Research, United Republic of Tanzania. Abbreviations
Footnotes Author contributions. GFK formulated the model in consultation with TAS; conceived the study hypothesis in consultation with HMF, SA, and SPK; applied the model to test this hypothesis; and drafted the manuscript in consultation with all the other authors. TAS, HM, SA, and CL participated in design of the ITN surveys and contributed to drafting of the manuscript. HMF, SA, and SPK contributed to formulation of the hypothesis and drafting of the manuscript. All authors approved the final submitted version of the manuscript. Funding: This study was supported by Swiss National Science Foundation (awards 2200C0-10594 and 3270-059541-99), Bill and Melinda Gates Foundation (award 39777), the Biotechnology and Biological Research Council of the United Kingdom (David Phillips Fellowship awarded to HMF), and the Wellcome Trust (Research Career Development Fellowship number 076806 awarded to GFK). These funding agencies had no role in the study design, data collction and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests exist. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nature. 2005 Mar 10; 434(7030):214-7.
[Nature. 2005]Science. 2001 Jul 27; 293(5530):694-8.
[Science. 2001]Malar J. 2003 Sep 19; 2():32.
[Malar J. 2003]Malar J. 2007 Jan 25; 6():10.
[Malar J. 2007]BMC Infect Dis. 2006 Nov 10; 6():161.
[BMC Infect Dis. 2006]Lancet. 2006 Jul 1; 368(9529):1.
[Lancet. 2006]Am J Trop Med Hyg. 2003 Apr; 68(4 Suppl):121-7.
[Am J Trop Med Hyg. 2003]Am J Trop Med Hyg. 2003 Apr; 68(4 Suppl):121-7.
[Am J Trop Med Hyg. 2003]Trop Med Int Health. 2002 Dec; 7(12):1003-8.
[Trop Med Int Health. 2002]Am J Trop Med Hyg. 2000 May; 62(5):535-44.
[Am J Trop Med Hyg. 2000]Malar J. 2004 Jun 4; 3():13.
[Malar J. 2004]Med Vet Entomol. 1989 Jul; 3(3):263-71.
[Med Vet Entomol. 1989]Nature. 2005 Nov 24; 438(7067):492-5.
[Nature. 2005]Trends Parasitol. 2001 Mar; 17(3):145-9.
[Trends Parasitol. 2001]Am J Trop Med Hyg. 2006 Aug; 75(2 Suppl):111-8.
[Am J Trop Med Hyg. 2006]Malar J. 2007 Jan 25; 6():10.
[Malar J. 2007]Am J Trop Med Hyg. 2003 Apr; 68(4 Suppl):121-7.
[Am J Trop Med Hyg. 2003]BMC Infect Dis. 2006 Nov 10; 6():161.
[BMC Infect Dis. 2006]Nature. 2005 Nov 24; 438(7067):492-5.
[Nature. 2005]Trends Parasitol. 2001 Mar; 17(3):145-9.
[Trends Parasitol. 2001]Bull World Health Organ. 2001; 79(10):998.
[Bull World Health Organ. 2001]Med Vet Entomol. 2004 Jun; 18(2):134-40.
[Med Vet Entomol. 2004]Annu Rev Entomol. 2001; 46():79-110.
[Annu Rev Entomol. 2001]Am J Trop Med Hyg. 2000 May; 62(5):535-44.
[Am J Trop Med Hyg. 2000]Am J Trop Med Hyg. 2000 May; 62(5):545-51.
[Am J Trop Med Hyg. 2000]Am J Trop Med Hyg. 2004 Aug; 71(2 Suppl):87-93.
[Am J Trop Med Hyg. 2004]Malar J. 2003 Sep 19; 2():32.
[Malar J. 2003]BMC Infect Dis. 2006 Nov 10; 6():161.
[BMC Infect Dis. 2006]Am J Trop Med Hyg. 2000 May; 62(5):535-44.
[Am J Trop Med Hyg. 2000]Am J Trop Med Hyg. 2004 Aug; 71(2 Suppl):87-93.
[Am J Trop Med Hyg. 2004]Trans R Soc Trop Med Hyg. 2001 Sep-Oct; 95(5):469-76.
[Trans R Soc Trop Med Hyg. 2001]Malar J. 2003 Sep 19; 2():32.
[Malar J. 2003]Malar J. 2007 Jan 25; 6():10.
[Malar J. 2007]BMC Infect Dis. 2006 Nov 10; 6():161.
[BMC Infect Dis. 2006]Am J Trop Med Hyg. 2004 Aug; 71(2 Suppl):87-93.
[Am J Trop Med Hyg. 2004]Trans R Soc Trop Med Hyg. 2001 Sep-Oct; 95(5):469-76.
[Trans R Soc Trop Med Hyg. 2001]Malar J. 2003 Sep 19; 2():32.
[Malar J. 2003]Malar J. 2007 Jan 25; 6():10.
[Malar J. 2007]Lancet Infect Dis. 2003 May; 3(5):297-303.
[Lancet Infect Dis. 2003]Nature. 2005 Nov 24; 438(7067):492-5.
[Nature. 2005]Am J Trop Med Hyg. 2006 Aug; 75(2 Suppl):11-8.
[Am J Trop Med Hyg. 2006]Lancet. 2000 Jun 3; 355(9219):1972.
[Lancet. 2000]Am J Trop Med Hyg. 2006 Aug; 75(2 Suppl):32-7.
[Am J Trop Med Hyg. 2006]Trans R Soc Trop Med Hyg. 2001 Sep-Oct; 95(5):469-76.
[Trans R Soc Trop Med Hyg. 2001]Proc Natl Acad Sci U S A. 2006 Nov 14; 103(46):17560-3.
[Proc Natl Acad Sci U S A. 2006]Malar J. 2003 Sep 19; 2():32.
[Malar J. 2003]Med Vet Entomol. 1989 Oct; 3(4):337-45.
[Med Vet Entomol. 1989]Malar J. 2005 May 13; 4(1):23.
[Malar J. 2005]Malar J. 2007 Jan 25; 6():10.
[Malar J. 2007]Bull World Health Organ. 1960; 22():721-34.
[Bull World Health Organ. 1960]J Vector Ecol. 2000 Jun; 25(1):48-61.
[J Vector Ecol. 2000]BMC Infect Dis. 2006 Nov 10; 6():161.
[BMC Infect Dis. 2006]Trans R Soc Trop Med Hyg. 2001 Sep-Oct; 95(5):469-76.
[Trans R Soc Trop Med Hyg. 2001]Am J Trop Med Hyg. 2004 Aug; 71(2 Suppl):87-93.
[Am J Trop Med Hyg. 2004]Malar J. 2003 Sep 19; 2():32.
[Malar J. 2003]Parasitology. 2000 Mar; 120 ( Pt 3)():319-27.
[Parasitology. 2000]Am J Trop Med Hyg. 2004 Aug; 71(2 Suppl):87-93.
[Am J Trop Med Hyg. 2004]Trans R Soc Trop Med Hyg. 2001 Sep-Oct; 95(5):469-76.
[Trans R Soc Trop Med Hyg. 2001]Am J Trop Med Hyg. 2000 May; 62(5):535-44.
[Am J Trop Med Hyg. 2000]Am J Trop Med Hyg. 2000 May; 62(5):545-51.
[Am J Trop Med Hyg. 2000]BMC Infect Dis. 2006 Nov 10; 6():161.
[BMC Infect Dis. 2006]Am J Trop Med Hyg. 2004 Aug; 71(2 Suppl):87-93.
[Am J Trop Med Hyg. 2004]Am J Trop Med Hyg. 2000 May; 62(5):535-44.
[Am J Trop Med Hyg. 2000]Malar J. 2004 Jun 4; 3():13.
[Malar J. 2004]Am J Trop Med Hyg. 1998 Aug; 59(2):252-7.
[Am J Trop Med Hyg. 1998]Am J Trop Med Hyg. 2000 May; 62(5):535-44.
[Am J Trop Med Hyg. 2000]Am J Trop Med Hyg. 2000 May; 62(5):545-51.
[Am J Trop Med Hyg. 2000]Am J Trop Med Hyg. 2000 May; 62(5):535-44.
[Am J Trop Med Hyg. 2000]Am J Trop Med Hyg. 2000 May; 62(5):545-51.
[Am J Trop Med Hyg. 2000]Am J Trop Med Hyg. 2006 Aug; 75(2 Suppl):38-45.
[Am J Trop Med Hyg. 2006]Am J Trop Med Hyg. 2006 Aug; 75(2 Suppl):32-7.
[Am J Trop Med Hyg. 2006]Am J Trop Med Hyg. 2000 May; 62(5):535-44.
[Am J Trop Med Hyg. 2000]Med Vet Entomol. 1987 Jan; 1(1):37-51.
[Med Vet Entomol. 1987]Am J Trop Med Hyg. 2004 Aug; 71(2 Suppl):87-93.
[Am J Trop Med Hyg. 2004]Trans R Soc Trop Med Hyg. 2001 Sep-Oct; 95(5):469-76.
[Trans R Soc Trop Med Hyg. 2001]Med Vet Entomol. 1987 Jan; 1(1):37-51.
[Med Vet Entomol. 1987]Trans R Soc Trop Med Hyg. 2001 Sep-Oct; 95(5):469-76.
[Trans R Soc Trop Med Hyg. 2001]Bull Entomol Res. 1969 Dec; 59(3):441-56.
[Bull Entomol Res. 1969]J Vector Ecol. 2000 Jun; 25(1):48-61.
[J Vector Ecol. 2000]Bull Entomol Res. 1969 Jul; 59(1):33-46.
[Bull Entomol Res. 1969]Trop Med Int Health. 2003 Jun; 8(6):512-7.
[Trop Med Int Health. 2003]Med Vet Entomol. 1989 Jul; 3(3):263-71.
[Med Vet Entomol. 1989]Med Vet Entomol. 1987 Jan; 1(1):37-51.
[Med Vet Entomol. 1987]BMC Infect Dis. 2006 Nov 10; 6():161.
[BMC Infect Dis. 2006]Med Vet Entomol. 1987 Jan; 1(1):37-51.
[Med Vet Entomol. 1987]Ann Trop Med Parasitol. 1994 Jun; 88(3):263-70.
[Ann Trop Med Parasitol. 1994]Trop Med Int Health. 2007 Apr; 12(4):532-9.
[Trop Med Int Health. 2007]J Vector Borne Dis. 2006 Mar; 43(1):1-6.
[J Vector Borne Dis. 2006]Trop Med Int Health. 2003 Jun; 8(6):512-7.
[Trop Med Int Health. 2003]Bull World Health Organ. 2001; 79(10):998.
[Bull World Health Organ. 2001]Med Vet Entomol. 2004 Jun; 18(2):134-40.
[Med Vet Entomol. 2004]Malar J. 2006 May 21; 5():44.
[Malar J. 2006]Am J Trop Med Hyg. 2003 Apr; 68(4 Suppl):121-7.
[Am J Trop Med Hyg. 2003]Malar J. 2007 Jan 25; 6():10.
[Malar J. 2007]BMC Infect Dis. 2006 Nov 10; 6():161.
[BMC Infect Dis. 2006]Bull World Health Organ. 2001; 79(10):998.
[Bull World Health Organ. 2001]BMC Infect Dis. 2006 Nov 10; 6():161.
[BMC Infect Dis. 2006]Med Vet Entomol. 1995 Jan; 9(1):50-8.
[Med Vet Entomol. 1995]Am J Trop Med Hyg. 2003 Apr; 68(4 Suppl):121-7.
[Am J Trop Med Hyg. 2003]Am J Trop Med Hyg. 2006 Aug; 75(2 Suppl):32-7.
[Am J Trop Med Hyg. 2006]Am J Trop Med Hyg. 2006 Aug; 75(2 Suppl):38-45.
[Am J Trop Med Hyg. 2006]Am J Trop Med Hyg. 2006 Aug; 75(2 Suppl):11-8.
[Am J Trop Med Hyg. 2006]Proc Natl Acad Sci U S A. 1997 Jan 7; 94(1):338-42.
[Proc Natl Acad Sci U S A. 1997]Am J Trop Med Hyg. 2003 Apr; 68(4 Suppl):121-7.
[Am J Trop Med Hyg. 2003]Lancet. 1995 Feb 25; 345(8948):479-83.
[Lancet. 1995]Am J Trop Med Hyg. 2003 Apr; 68(4 Suppl):23-9.
[Am J Trop Med Hyg. 2003]Lancet Infect Dis. 2003 May; 3(5):304-7.
[Lancet Infect Dis. 2003]Lancet Infect Dis. 2003 Aug; 3(8):465-6; discussion 467-8.
[Lancet Infect Dis. 2003]Am J Trop Med Hyg. 2006 Aug; 75(2 Suppl):11-8.
[Am J Trop Med Hyg. 2006]Proc Natl Acad Sci U S A. 1997 Jan 7; 94(1):338-42.
[Proc Natl Acad Sci U S A. 1997]Bull World Health Organ. 2005 Mar; 83(3):195-201.
[Bull World Health Organ. 2005]Lancet. 2006 Jul 1; 368(9529):1.
[Lancet. 2006]Malar J. 2006 May 21; 5():44.
[Malar J. 2006]Bull World Health Organ. 2003; 81(4):269-76.
[Bull World Health Organ. 2003]Bull World Health Organ. 2005 Mar; 83(3):195-201.
[Bull World Health Organ. 2005]Malar J. 2007 Jan 29; 6():13.
[Malar J. 2007]Malar J. 2007 Feb 2; 6():14.
[Malar J. 2007]Lancet Infect Dis. 2005 Nov; 5(11):709-17.
[Lancet Infect Dis. 2005]Am J Trop Med Hyg. 2005 Sep; 73(3):622-5.
[Am J Trop Med Hyg. 2005]Trop Med Int Health. 2002 Oct; 7(10):813-22.
[Trop Med Int Health. 2002]Nature. 1964 Dec 19; 204():1173-5.
[Nature. 1964]Science. 2002 Oct 4; 298(5591):96-7.
[Science. 2002]Emerg Infect Dis. 2007 Feb; 13(2):199-206.
[Emerg Infect Dis. 2007]Am J Trop Med Hyg. 2003 Apr; 68(4 Suppl):121-7.
[Am J Trop Med Hyg. 2003]Lancet. 2006 Jul 1; 368(9529):1.
[Lancet. 2006]